Population pharmacokinetics of abacavir in plasma and cerebrospinal fluid
- PMID: 15917556
- PMCID: PMC1140502
- DOI: 10.1128/AAC.49.6.2504-2506.2005
Population pharmacokinetics of abacavir in plasma and cerebrospinal fluid
Abstract
The distribution of abacavir into the cerebrospinal fluid (CSF) was assessed by use of a population pharmacokinetic analysis. Plasma and CSF abacavir concentrations in 54 subjects were determined. The abacavir CSF/plasma ratio averaged 36% and increased throughout the dose interval. Abacavir penetrates into the CSF in adequate concentrations to inhibit local human immunodeficiency virus replication.
Figures
References
-
- Beal, S. L., and L. B. Sheiner (ed.). 1992. NONMEM user guides. NONMEM Project Group, University of California, San Francisco.
-
- Cherubin, C. E., R. H. Eng, R. Norrby, J. Modai, G. Humbert, and G. Overturf. 1989. Penetration of newer cephalosporins into cerebrospinal fluid. Rev. Infect. Dis. 11:526-548. - PubMed
-
- Daluge, S. M., S. S. Good, M. B. Faletto, W. H. Miller, M. H. St. Clair, L. R. Boone, M. Tisdale, N. R. Parry, J. E. Reardon, R. E. Dornsife, D. R. Averett, and T. A. Krenitsky. 1997. 1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity. Antimicrob. Agents Chemother. 41:1082-1093. - PMC - PubMed
-
- Ellis, R. J., A. C. Gamst, E. Capparelli, S. A. Spector, K. Hsia, T. Wolfson, I. Abramson, I. Grant, and J. A. McCutchan. 2000. Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology 54:927-936. - PubMed
-
- Foudraine, N. A., R. M. Hoetelmans, J. M. Lange, F. de Wolf, B. H. van Benthem, J. J. Maas, I. P. Keet, and P. Portegies. 1998. Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine. Lancet 351:1547-1551. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
